Taltz
Chemical Name | ixekizumab |
Dosage Form | Injection (subcutaneous; 80 mg/6 mL) |
Drug Class | Monoclonal antibodies |
System | Musculoskeletal, Skin |
Company | Eli Lilly and Company |
Approval Year | 2016 |
Indication
- To treat adults with moderate-to-severe plaque psoriasis.
- To treat active ankylosing spondylitis.
- To treat active psoriatic arthritis.